Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Study provides evidence that BRONJ is a rare occurrence.

FGDPUK BRONJ Steering Group.

Prim Dent J. 2013 Jan;2(1):11. No abstract available.

PMID:
23717883
2.

Incidence and risk factors of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients having undergone autologous stem cell transplantation.

Then C, Hörauf N, Otto S, Pautke C, von Tresckow E, Röhnisch T, Baumann P, Schmidmaier R, Bumeder I, Oduncu FS.

Onkologie. 2012;35(11):658-64. doi: 10.1159/000343950. Epub 2012 Oct 22.

PMID:
23147542
3.

Bisphosphonate-related osteonecrosis of the jaws.

Kushner GM, Alpert B.

Curr Opin Otolaryngol Head Neck Surg. 2011 Aug;19(4):302-6. doi: 10.1097/MOO.0b013e328348b257.

PMID:
21677585
4.

Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jaws.

Conte-Neto N, Bastos AS, Marcantonio RA, Junior EM.

Head Face Med. 2012 Mar 1;8:5. doi: 10.1186/1746-160X-8-5. Review.

5.

Accurate approach in the treatment of oral bisphosphonate-related jaw osteonecrosis.

de Souza Faloni AP, Queiroz TP, Comelli Lia RC, Cerri PS, Margonar R, Rastelli AN, Marcantonio E.

J Craniofac Surg. 2011 Nov;22(6):2185-90. doi: 10.1097/SCS.0b013e318232410b. Review.

PMID:
22075816
6.

Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.

O'Ryan FS, Lo JC.

J Oral Maxillofac Surg. 2012 Aug;70(8):1844-53. doi: 10.1016/j.joms.2011.08.033. Epub 2012 May 16.

PMID:
22595135
7.

Prevalence of cone beam computed tomography imaging findings according to the clinical stage of bisphosphonate-related osteonecrosis of the jaw.

Wilde F, Heufelder M, Lorenz K, Liese S, Liese J, Helmrich J, Schramm A, Hemprich A, Hirsch E, Winter K.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Dec;114(6):804-11. doi: 10.1016/j.oooo.2012.08.458.

PMID:
23159120
8.

Characteristics of bisphosphonate-related osteonecrosis of the jaw after kidney transplantation.

Park W, Lee SH, Park KR, Rho SH, Chung WY, Kim HJ.

J Craniofac Surg. 2012 Sep;23(5):e510-4. doi: 10.1097/SCS.0b013e31825b33f6.

PMID:
22976726
9.

Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws.

Wutzl A, Pohl S, Sulzbacher I, Seemann R, Lauer G, Ewers R, Drach J, Klug C.

Head Neck. 2012 Feb;34(2):194-200. doi: 10.1002/hed.21708. Epub 2011 Mar 11.

PMID:
21400630
10.

Bisphosphonate osteonecrosis of the jaw: a historical and contemporary review.

McLeod NM, Brennan PA, Ruggiero SL.

Surgeon. 2012 Feb;10(1):36-42. doi: 10.1016/j.surge.2011.09.002. Epub 2011 Oct 7. Review.

PMID:
22233554
11.

A role for C-terminal cross-linking telopeptide (CTX) level to predict the development of bisphosphonate-related osteonecrosis of the jaws (BRONJ) following oral surgery?

O'Connell JE, Ikeagwani O, Kearns GJ.

Ir J Med Sci. 2012 Jun;181(2):237-42. doi: 10.1007/s11845-011-0790-5. Epub 2012 Jan 6.

PMID:
22223192
12.

Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosis.

Schaudinn C, Gorur A, Webster P, Jones AC, Neely M, Jelliffe RW, Le AD, Sedghizadeh PP.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Oct;114(4):480-6. doi: 10.1016/j.oooo.2012.06.006.

PMID:
22986243
13.

[Bisphosphonate-associated jaw osteonecrosis].

García Sanz R.

Med Clin (Barc). 2012 Dec 15;139(15):674-5. doi: 10.1016/j.medcli.2012.07.019. Epub 2012 Oct 25. Spanish. No abstract available.

PMID:
23103105
14.

Incidence of serious side effects with intravenous bisphosphonate: a clinical audit.

Powell D, Bowler C, Roberts T, Garton M, Matthews C, McCall I, Davie M.

QJM. 2012 Oct;105(10):965-71. Epub 2012 Jun 28.

15.

Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction.

Saia G, Blandamura S, Bettini G, Tronchet A, Totola A, Bedogni G, Ferronato G, Nocini PF, Bedogni A.

J Oral Maxillofac Surg. 2010 Apr;68(4):797-804. doi: 10.1016/j.joms.2009.10.026.

PMID:
20307765
16.

Bisphosphonate related osteonecrosis of the jaw: A minipig large animal model.

Pautke C, Kreutzer K, Weitz J, Knödler M, Münzel D, Wexel G, Otto S, Hapfelmeier A, Stürzenbaum S, Tischer T.

Bone. 2012 Sep;51(3):592-9. doi: 10.1016/j.bone.2012.04.020. Epub 2012 May 7.

PMID:
22575441
17.

[Bisphosphonate related osteonecrosis of the jaw].

Cuervo Pinna MÁ.

Med Clin (Barc). 2013 Aug 4;141(3):133. doi: 10.1016/j.medcli.2012.12.022. Epub 2013 Apr 21. Spanish. No abstract available.

PMID:
23611820
18.

Electrically conductive bacterial nanowires in bisphosphonate-related osteonecrosis of the jaw biofilms.

Wanger G, Gorby Y, El-Naggar MY, Yuzvinsky TD, Schaudinn C, Gorur A, Sedghizadeh PP.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jan;115(1):71-8. doi: 10.1016/j.oooo.2012.08.446.

PMID:
23217537
19.

Anatomic factors related to bisphosphonate osteonecrosis of the jaws: a Portuguese retrospective study.

Álvares Furtado I, Franco Caldas C, Lança F, Salvado e Silva F.

Acta Med Port. 2012 Mar-Apr;25(2):106-10. Epub 2012 Jun 25.

20.

The outcomes of conservative and surgical treatment of stage 2 bisphosphonate-related osteonecrosis of the jaws: a case series.

Jabbour Z, El-Hakim M, Mesbah-Ardakani P, Henderson JE, Albuquerque R Jr.

Int J Oral Maxillofac Surg. 2012 Nov;41(11):1404-9. doi: 10.1016/j.ijom.2012.05.012. Epub 2012 Jun 14. Review.

PMID:
22704590
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk